ABC-03 : a randomized, phase II/III study of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine for patients with advanced biliary tract cancers

Author(s)

Journal

  • J Clin Oncol

    J Clin Oncol 28(Suppl abstr), 2010

Cited by:  1

Codes

  • NII Article ID (NAID)
    10030950776
  • Article Type
    Journal Article
  • Data Source
    CJPref 
Page Top